IO Biotech, Inc. Gains 131.26%

Thu, Jan 22, 2026 at 07:22 PM

IO Biotech, Inc. (IOBT:NASDAQ) rocketted at $0.48, representing a gain of 131.3%. On Thu, Jan 22, 2026, IOBT:NASDAQ touched a New 2-Week Intraday High of $0.58. The stock appeared on our News Catalysts scanner on Wed, Jan 21, 2026 at 01:26 PM in the 'BIOTECH' category. From Thu, Jan 08, 2026, the stock recorded 44.44% Up Days and 30.00% Green Days

The stock spiked on Mon, Aug 18, 2025 at $2.79 with a volume of 13M+.

About IO Biotech, Inc. (IOBT:NASDAQ)

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform.

Top 10 Gainers:

60 Degrees Pharmaceuticals, Inc. (SXTP:NASDAQ), 152%
IO Biotech, Inc. (IOBT:NASDAQ), 131.26%
Pheton Holdings Ltd (PTHL:NASDAQ), 105.16%
Blue Gold Limited (BGL:NASDAQ), 103.83%
Namib Minerals (NAMM:NASDAQ), 83.63%
iOThree Limited (IOTR:NASDAQ), 74.06%
Captivision Inc. (CAPT:NASDAQ), 49.63%
Ambitions Enterprise Management Co. L.L.C (AHMA:NASDAQ), 41.75%
Regencell Bioscience Holdings Limited (RGC:NASDAQ), 40.44%
Burning Rock Biotech Limited (BNR:NASDAQ), 34.33%